FDA, Generics Industry Urge Congress to Reauthorize GDUFA
By

By
At a recent Congressional hearing, representatives from the FDA and the Association for Accessible Medicines (formerly the Generic Pharmaceutical Association) called on Congress to pass re-authorization of the Generic Drug User…

FDA Issues Warning Letter to Sato Pharmaceutical
By

By
The US Food and Drug Administration (FDA) has posted a Warning Letter to Sato Pharmaceutical, a Tokyo-headquartered manufacturer of over-the-counter drugs, following an inspection of the company’s drug manufacturing facility…

Eisai to Market Parkinson’s Disease Drugs
By

By
Eisai has entered into a marketing and distribution agreement in China with Orion Corporation, an Espoo, Finland-headquartered, pharmaceutical company, for two of Orion’s Parkinson’s disease drugs, Comtan (entacapone) and Stalevo…

Gilead Sells Anti-Addiction Drug
By

By
Gilead Sciences has agreed to sell its aldehyde dehydrogenase 2 (ALDH2) inhibitor, a drug candidate with the potential to treat behavior and substance addictions, to Amygdala Neurosciences, a Palo Alto,…

Teva Recalls Nearly 500,000 Units of Diabetes Drug
By

By
Teva Pharmaceutical Industries has issued a Class II voluntarily recall of 499,320 units of glipizide extended-release tablets, 2.5mg, a drug for treating Type 2 diabetes, due to the drug missing…

Takeda to Establish Joint Venture
By

By
Takeda Pharmaceutical has partnered with PRA Health Sciences, a Raleigh, North Carolina-based contract research organization, to establish a 50/50 joint venture in Japan to provide clinical trial delivery and pharmacovigilance…

Janssen Expands Inflammatory Drug Research Pact
By

By
Janssen Biotech, one of the Janssen Pharmaceutical Companies of Johnson & Johnson (J&J), has expanded its collaboration with X-Chem, a Waltham, Massachusetts-based privately-owned biotechnology company, to discover new drug leads…

Bioverativ, Sobi Partner on Hemophilia Drug
By

By
Swedish Orphan Biovitrum (Sobi), a Stockholm, Sweden-headquartered specialty healthcare company, has elected to add a product candidate for the potential treatment of hemophilia B to the company’s collaboration agreement with…

Dr. Reddy’s Expands Hospital Generics Business in Europe
By

By
Dr. Reddy’s Laboratories has expanded its commercial operations in Europe with the introduction of its generic drug portfolio in France, where the company plans to make its generic products available…

Pfizer’s CMO Unit Expands Fill-Finish Services
By

By
Pfizer CentreOne, a global contract manufacturing organization (CMO) embedded within Pfizer, has expanded its fill-finish services at its Kalamazoo, Michigan site. The facility now provides vial-filling of sterile suspensions along…